Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Supranuclear Palsy, Progressive 1Spinocerebellar Ataxias 1Spastic Paraplegia, Hereditary 1Obesity 1Neuromuscular Diseases 1Myotonic Dystrophy 1Myasthenia Gravis 1Muscular Dystrophy, Facioscapulohumeral 1Lambert-Eaton Myasthenic Syndrome 1Huntington Disease 1Charcot-Marie-Tooth Disease 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Walk Test × 1 year × Clear all
NCT07136844 2025-08-22

Acti-Adult

Centre Hospitalier Universitaire de Liege

Phase NA Recruiting
300 enrolled
Other

Charcot-Marie-Tooth Disease, Huntington Disease, Myasthenia Gravis, Myotonic Dystrophy, Neuromuscular Diseases, Obesity, Supranuclear Palsy, Progressive, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Facioscapulohumeral, Spinocerebellar Ataxias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡